Evotec SE (OTCMKTS:EVTCY – Get Free Report)’s stock price passed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $3.76 and traded as low as $3.30. Evotec shares last traded at $3.3450, with a volume of 178,223 shares changing hands.
Evotec Stock Down 6.8%
The company has a market capitalization of $1.02 billion, a price-to-earnings ratio of 7.51 and a beta of 0.98. The company has a current ratio of 2.57, a quick ratio of 2.50 and a debt-to-equity ratio of 0.53. The firm’s 50 day simple moving average is $3.75 and its 200-day simple moving average is $3.94.
About Evotec
Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.
Featured Articles
- Five stocks we like better than Evotec
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Rivian’s Chart Says Go, But Some Analysts Still Say No
- Growth Stocks: What They Are, What They Are Not
- e.l.f. Sell-Off Is a Good Time to Buy, According to Analysts
- What is Forex and How Does it Work?
- T-Mobile Is The Most Oversold Mega-Cap Stock—Time to Buy?
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
